OTTAWA – A vendor in Atlantic Canada (www.health-recovery-info.com) is selling Miracle Mineral Solution (MMS), an unauthorized drug product which Health Canada has previously warned may pose serious risks to health if ingested. This product, which is a chemical used mainly as a textile bleaching agent and disinfectant, is being promoted as a cure for cancer, HIV, flu and malaria by the company.
Who is affected:
Canadians who have purchased Miracle Mineral Solution or Master Mineral Solution products on the Internet from the website www.health-recovery-info.com.
What consumers should do:
- Stop using Miracle Mineral Solution products immediately.
- Consult your doctor or pharmacist if you have used or are using Miracle Mineral Solution products distributed bywww.health-recovery-info.com or any other distributor.
- Report any adverse events to Health Canada.
What Health Canada is doing:
Health Canada notified www.health-recovery-info.com that the sale of this product is not permitted under the Food and Drugs Act and its regulations. The company has not taken the necessary steps to come into compliance with regulatory requirements.
In order to protect the health and safety of Canadians, Health Canada will consider the use of other enforcement measures to stop the company from selling the product.
Background:
Miracle Mineral Solution contains sodium chlorite. No drug products containing sodium chlorite have been approved by Health Canada for consumption by humans. Sodium chlorite is authorized in Canada for use as a germicide by veterinarians and as a hard surface disinfectant. Sodium chlorite is commonly used for bleaching textiles, pulp and paper, as well as in the generation of disinfectant for water treatment.
Products Affected:
MMS Package contains two (2) bottles: one labelled to contain 28% Sodium Chlorite and Distilled Water and the other labelled to contain 50% Citric Acid.
For more information:
Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.
